The German Institute for Quality and Efficiency in Health Care reported this year that PSA testing increases prostate cancer diagnoses and reduces long-term disease-specific mortality, but it also results in overdiagnosis and treatment-related harm [9]. The gene discussed is KLK3; the disease is prostate cancer.